Cargando…

From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

Detalles Bibliográficos
Autor principal:	DeFronzo, Ralph A.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Banting Lecture
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661582/ https://www.ncbi.nlm.nih.gov/pubmed/19336687 http://dx.doi.org/10.2337/db09-9028

Ejemplares similares

Pathogenesis of Fasting and Postprandial Hyperglycemia in Type 2 Diabetes: Implications for Therapy
por: Rizza, Robert A.
Publicado: (2010)

Banting Lecture 2009: An Unfinished Journey: Molecular Pathogenesis to Prevention of Type 1A Diabetes
por: Eisenbarth, George S.
Publicado: (2010)

The Multifaceted Roles of Adipose Tissue—Therapeutic Targets for Diabetes and Beyond: The 2015 Banting Lecture
por: Scherer, Philipp E.
Publicado: (2016)

Banting Lecture 2012: Regulation of Adipogenesis: Toward New Therapeutics for Metabolic Disease
por: Spiegelman, Bruce M.
Publicado: (2013)

Bringing Light to the Dark Side of Insulin: A Journey Across the Blood-Brain Barrier
por: Sherwin, Robert S.
Publicado: (2008)

Banting Lecture 2011: Hyperinsulinemia: Cause or Consequence?
por: Corkey, Barbara E.
Publicado: (2012)

Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
por: DeFronzo, Ralph A.
Publicado: (2011)

Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment
por: Triplitt, Curtis, et al.
Publicado: (2010)

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
por: DeFronzo, Ralph A., et al.
Publicado: (2009)

Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type
por: Miyazaki, Yoshinori, et al.
Publicado: (2009)

Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention
por: DeFronzo, Ralph A., et al.
Publicado: (2011)

Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus
por: Al Jobori, Hussein, et al.
Publicado: (2018)

Mechanism of Action of Inhaled Insulin on Whole Body Glucose Metabolism in Subjects with Type 2 Diabetes Mellitus
por: Mehta, Rucha J., et al.
Publicado: (2019)

Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes
por: Abdul-Ghani, Muhammad A., et al.
Publicado: (2009)

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: The time has come for GLP-1 receptor agonists!
por: Schwartz, Stanley, et al.
Publicado: (2013)

Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes
por: DeFronzo, Ralph A., et al.
Publicado: (2022)

Diet, Microbiome, and the Intestinal Epithelium: An Essential Triumvirate?
por: Guzman, Javier Rivera, et al.
Publicado: (2013)

RLIP76: A Structural and Functional Triumvirate
por: Cornish, Jasmine, et al.
Publicado: (2021)

Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus
por: Wal, Pranay, et al.
Publicado: (2023)

Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
por: DeFronzo, Ralph A., et al.
Publicado: (2013)

Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
por: Krolewski, Andrzej S.
Publicado: (2015)

Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
por: DeFronzo, R. A.
Publicado: (2010)

Triumvirate Presentation and Treatment of Psoriasis in the Setting of HIV and Treponema pallidum Infection
por: Kidron, Ariel, et al.
Publicado: (2022)

Beware of the ominous folds
por: Balijepalli, Pasyanthi, et al.
Publicado: (2020)

Mitochondrial homeostasis in Parkinson’s disease - a triumvirate rule?
por: Ng, Chee-Hoe, et al.
Publicado: (2017)

Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?
por: Perdomo, Carolina M., et al.
Publicado: (2021)

The crossing matrix in the octet model
por: De Swart, J J
Publicado: (1964)

Retraction: Triumvirate Presentation and Treatment of Psoriasis in the Setting of HIV and Treponema pallidum Infection
por: Kidron, Ariel, et al.
Publicado: (2022)

Thoracolumbar injury classification and severity score: a new paradigm for the treatment of thoracolumbar spine trauma
por: Lee, Joon Y., et al.
Publicado: (2005)

Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Color-octet scalars at the LHC
por: Choi, S Y, et al.
Publicado: (2009)

Portrait of a colour octet
por: Aguilar-Saavedra, J.A.
Publicado: (2014)

Comment on Piccinini and Bergman. The Measurement of Insulin Clearance. Diabetes Care 2020;43:2296–2302
por: Gastaldelli, Amalia, et al.
Publicado: (2021)

The exotic baryon mass spectrum and the decuplet-octet and antidecuplet-octet mass difference in the Skyrme model
por: Duplancic, G., et al.
Publicado: (2004)

From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes
por: Mosenzon, Ofri, et al.
Publicado: (2021)

Beta Cell Formation in vivo Through Cellular Networking, Integration and Processing (CNIP) in Wild Type Adult Mice
por: Doiron, Bruno, et al.
Publicado: (2016)

Erratum. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care 2017;40:813–820
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19
por: Shah, Harsh, et al.
Publicado: (2021)

The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
por: Attiq, Ali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ru87ejihng0fau6qoeccr7qjp4